Ten states filed a brief in U.S. District Court in Washington defending their right to implement restricted drug formularies for Medicaid and to seek special rebates from manufacturers with products on the preferred list. Last month the drug industry's trade group, the Pharmaceutical Research and Manufacturers of America, filed a lawsuit to block a Michigan program that would create a Medicaid preferred drug list. An effort by Maine to extend Medicaid pharmaceutical discounts to uninsured residents has been tied up in litigation and is now before the U.S. Supreme Court. In the brief filed yesterday, 10 states -- including Florida, Hawaii, Louisiana, Maine and Missouri -- argued that the court shouldn't halt innovative programs in Michigan and elsewhere that help states maintain Medicaid drug benefits. PhRMA was unavailable for comment at deadline. -- by Jeff Tieman
States defend efforts to cut Medicaid drug costs
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.